Announcement of Intent To Establish Federal Advisory Committee on Long COVID, 80319-80320 [2023-24586]
Download as PDF
<![CDATA[
80319
Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Total ..............................................................................................
a Number
Average
number of
responses per
respondent
Number of
respondents
Form name
786
........................
Total
number of
responses
I
4,242
Average
burden per
response
(in minutes)
I ........................
Total
burden
hours
1,251
of respondents is based on the current number of transplant programs and is likely to increase as additional programs decide to par-
ticipate.
b Number of living organ donor candidates submitting follow-up forms in 2019.
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–25368 Filed 11–16–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Intent To Establish
Federal Advisory Committee on Long
COVID
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services announces the intent to
establish an Advisory Committee on
Long COVID and invites nominations
for the Committee.
DATES: Nominations must be submitted
by 11:59 p.m. eastern time on January
16, 2024.
ADDRESSES: Nominations may be
submitted by email to LongCOVID@
hhs.gov and addressed to Allison
O’Donnell. 202–690–7694.
FOR FURTHER INFORMATION CONTACT:
Allison O’Donnell at 202–690–7694 or
LongCOVID@hhs.gov.
SUPPLEMENTARY INFORMATION: The
Committee is authorized under 42
U.S.C. 217a, section 222 of the Public
Health Service Act, as amended. The
Committee is governed by the
provisions of the Federal Advisory
Committee Act, Public Law 92–463, as
amended (5 U.S.C. chapter 10), which
sets forth standards for the formation
and use of advisory committees.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:57 Nov 16, 2023
Jkt 262001
The April 5, 2022, Memorandum
(https://www.whitehouse.gov/briefingroom/presidential-actions/2022/04/05/
memorandum-on-addressing-the-longterm-effects-of-covid-19/) on Addressing
the Long-term Effects of COVID–19
charged the Secretary of Health and
Human Services (Secretary) with
coordinating a Government-wide
response to the longer-term effects of
COVID–19. The Secretary named the
Assistant Secretary for Health to
coordinate the U.S. Government
response to Long COVID. The
Memorandum specified development
and publication of two reports that were
published August 3, 2022. One of the
reports, the National Research Action
Plan on Long COVID (https://
www.covid.gov/assets/files/NationalResearch-Action-Plan-on-Long-COVID08012022.pdf), called for the
establishment of a Secretary’s Advisory
Committee on Long COVID. The
Committee will bring perspectives from
outside the Government to help inform
action of the Executive Branch on Long
COVID and associated conditions, with
a focus on health equity. Numerous
entities across the U.S. Government
fund and conduct research and use
external advisory bodies. This Federal
Advisory Committee does not replace or
supersede the ongoing work of these
advisory bodies.
Structure: The Committee will consist
of up to 20 members, including any
Chair, Vice Chair, or Co-Chairs. Factors
to be considered in selecting individuals
to serve on the Committee include
expertise in the issues to be examined
by the Committee, as well as statutory
obligations under FACA and desire for
a balanced and diverse membership. To
the extent possible, composition of the
Committee will reflect the experience of
an inclusive and diverse cross-section of
persons with Long COVID and
multidisciplinary expertise of those
supporting and caring for those affected
as well as specific clinical, medical,
public health, behavioral health, human
services, employment, data science, and
research expertise. The membership of
the Committee will reflect diverse
individuals or organizations including
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
underserved populations, with a focus
on health equity.
The following areas of expertise will
be considered in selecting the voting
members with the goal of achieving a
balanced membership in terms of points
of view, expertise, and groups
represented and functions to be
performed by the Committee.
Long COVID and related groups:
Representation from individuals living
with Long COVID and organizations
directly engaged in supporting people
living with Long COVID.
Professional Associations:
Representation from medical
professional, behavioral health and
human services associations
representing practitioners caring for
people with Long COVID, including
those representing the primary
healthcare system.
Disability and Chronic Illness Groups:
Representation from associations,
researchers, or organizations focused on
disability and chronic illness, and their
possible interplay with Long COVID.
Public Health and related groups:
Representation from public health
groups supporting communities in
addressing the impacts of Long COVID.
Healthcare and Social Care Providers:
Clinical care settings and health systems
involved in providing care for patients
with Long COVID, including in
underserved areas, such as rural
communities and communities
disproportionately impacted by Long
COVID.
Employee and Employer Related
Groups: Representation from employee
and employer experts, attorneys, or
organizations involved in addressing the
impacts of Long COVID in the
workplace, including discrimination.
Research: Researchers and research
institutions involved in Long COVID
and associated conditions research.
Non-voting Industry Representatives:
Those involved in, or representing those
involved in, Long COVID research and
development, including prevention,
diagnostics, and treatment will be
designated to represent the interests of
this sector.
E:\FR\FM\17NON1.SGM
17NON1
khammond on DSKJM1Z7X2PROD with NOTICES
80320
Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices
Non-voting Federal Liaisons, without
limit, may be solicited, as needed, as ex
officio members.
Equal opportunity practices regarding
membership appointments to the
Committee will be aligned with HHS
policies. To the extent possible, HHS
will ensure the Committee membership
is balanced in expertise, experience,
education, and institutional affiliation.
Members of the Committee will be
classified as Special Government
Employees (SGE) during their term of
appointment and, as such, are subject to
the ethical standards of conduct for
federal employees. Upon entering the
position and annually throughout the
term of appointment, members of the
Committee will be required to complete
and submit a report of their financial
holdings.
Nominations and Appointments for
Memberships: Nominees, including selfnominees, will be considered for
appointment as members of the
Committee. Only complete nomination
packages submitted on time will be
considered. To be considered for an
appointment, submission of the
following information for each nominee
is required: (1) a cover letter that clearly
states the name and place of work of the
nominee, the rationale for the
nomination, and a statement that the
nominee would be willing to serve as a
member of the Committee, if selected;
(2) the name, address, telephone
number, and email address for the
individual being nominated and the
nominator, if applicable; and (3) a copy
of the nominee’s resume or curriculum
vitae. Nominees with no professional
affiliation may submit an optional letter
of recommendation.
The curriculum vitae should include
the following information: (a) education;
(b) experience (current and former); (c)
affiliations; (d) current memberships
(expert panels, committees, or other
relevant groups, including positions
held); (e) any peer-reviewed
publications (for past 5 years); (f) any
oral presentations (for past 5 years); (g)
editorials, opinion pieces, and blogs (for
past 5 years); (h) grants, contracts, or
research funding (for past 15 years); (i)
name of any corporation, professional
society, association, panel, company,
firm, government agency (Federal, State,
and local), research organization,
educational institution, committee, or
other organization or institution
(government, private, and not-for-profit;
domestic and foreign) in which the
nominee’s services have been, will be,
or are expected to be provided, with or
without compensation, including on a
part-time or seasonal basis as an officer,
medical staff, board member, owner,
VerDate Sep<11>2014
18:57 Nov 16, 2023
Jkt 262001
trustee, director, expert advisor,
consultant (paid or unpaid), official
spokesperson, member of speakers
bureau, or expert witness (for past 5
years and upcoming); (j) other paid
travel or honoraria received, not
included above (for past 5 years). If the
nominee does not have anything to
report for the sections, indicate ‘‘none.’’
Web links to publications,
presentations, and other materials
available online are requested, when
available.
Where prohibited by Federal law or
regulations, nominations will not be
accepted directly from HHS research
and promotion boards. Self-nominations
and nominations by members of
research and promotion boards in their
individual capacity will be considered.
Federal employees should not be
nominated for consideration for
appointment to this Committee.
Dated: November 2, 2023.
Xavier Becerra,
Secretary, Department of Health and Human
Services.
[FR Doc. 2023–24586 Filed 11–16–23; 8:45 am]
BILLING CODE 4150–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Neurological Disorders and Stroke
Special Emphasis Panel, November 27,
2023, 09:00 a.m. to November 29, 2023,
06:00 p.m., Crowne Plaza National
Airport, 1480 Crystal Drive, Arlington,
VA 22202 which was published in the
Federal Register on September 25, 2023,
88 FR 67334.
This notice is being amended to
change the location to Canopy by
Hilton, 940 Rose Avenue, North
Bethesda, MD 20852, and change the
meeting times to 10:00 a.m. to 6:00 p.m.
The meeting dates remains the same.
The meeting is closed to the public.
Dated: November 13, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–25403 Filed 11–16–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Amended Notice
of Meeting
Notice is hereby given of an amended
meeting notice of the Advisory
Committee to the Director, National
Institutes of Health, December 14–15,
2023, open meeting that was published
in the Federal Register on November 13,
2023, 88 FR 77595.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee to
the Director, National Institutes of
Health.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below. Members
of the public are encouraged to attend
virtually as space is limited.
Individuals who plan to attend as
well as those who need special
assistance or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The meeting can be
accessed from the NIH Videocast at the
following link: https://
videocast.nih.gov/ as space is limited.
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: December 14, 2023.
Time: 9:00 a.m. to 4:45 p.m.
Agenda: NIH Director’s Report; NIH Public
Access Plan; Cancer Moonshot; Addressing
the Mental Health Crisis through Research;
Assessing the Public Health Threat of PostAcute Sequelae of SARS CoV–2 Infection
(PASC)—NIH RECOVER Initiative: Briefing
for the Advisory Committee to the Director
(ACD); The Foundation for the National
Institutes of Health (FNIH); Other Business of
the Committee.
Date: December 15, 2023.
Time: 9:00 a.m. to 2:45 p.m.
Agenda: HeLa Genome Data Access
Working Group: Data Access Requests; NIHWide Collaborative Initiative on Climate
Change and Health; Clinical Trial
Stewardship; Accessibility Update; Update
from the ACD Working Group on Catalyzing
the Development and Use of Novel
Alternative Methods to Advance Biomedical
Research; Update from the ACD Working
Group on Re-envisioning NIH-Supported
Postdoctoral Training; Other Business of the
Committee.
Place: National Institutes of Health,
Building 1, Wilson Hall, One Center Drive,
Bethesda, MD 20892.
Contact Person: Cyndi Burrus-Shaw, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–2433, shawcy@od.nih.gov
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 88, Number 221 (Friday, November 17, 2023)]
[Notices]
[Pages 80319-80320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24586]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Announcement of Intent To Establish Federal Advisory Committee on
Long COVID
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services announces the
intent to establish an Advisory Committee on Long COVID and invites
nominations for the Committee.
DATES: Nominations must be submitted by 11:59 p.m. eastern time on
January 16, 2024.
ADDRESSES: Nominations may be submitted by email to [email protected]
and addressed to Allison O'Donnell. 202-690-7694.
FOR FURTHER INFORMATION CONTACT: Allison O'Donnell at 202-690-7694 or
[email protected].
SUPPLEMENTARY INFORMATION: The Committee is authorized under 42 U.S.C.
217a, section 222 of the Public Health Service Act, as amended. The
Committee is governed by the provisions of the Federal Advisory
Committee Act, Public Law 92-463, as amended (5 U.S.C. chapter 10),
which sets forth standards for the formation and use of advisory
committees.
The April 5, 2022, Memorandum (https://www.whitehouse.gov/briefing-room/presidential-actions/2022/04/05/memorandum-on-addressing-the-long-term-effects-of-covid-19/) on Addressing the Long-term Effects of
COVID-19 charged the Secretary of Health and Human Services (Secretary)
with coordinating a Government-wide response to the longer-term effects
of COVID-19. The Secretary named the Assistant Secretary for Health to
coordinate the U.S. Government response to Long COVID. The Memorandum
specified development and publication of two reports that were
published August 3, 2022. One of the reports, the National Research
Action Plan on Long COVID (https://www.covid.gov/assets/files/National-Research-Action-Plan-on-Long-COVID-08012022.pdf), called for the
establishment of a Secretary's Advisory Committee on Long COVID. The
Committee will bring perspectives from outside the Government to help
inform action of the Executive Branch on Long COVID and associated
conditions, with a focus on health equity. Numerous entities across the
U.S. Government fund and conduct research and use external advisory
bodies. This Federal Advisory Committee does not replace or supersede
the ongoing work of these advisory bodies.
Structure: The Committee will consist of up to 20 members,
including any Chair, Vice Chair, or Co-Chairs. Factors to be considered
in selecting individuals to serve on the Committee include expertise in
the issues to be examined by the Committee, as well as statutory
obligations under FACA and desire for a balanced and diverse
membership. To the extent possible, composition of the Committee will
reflect the experience of an inclusive and diverse cross-section of
persons with Long COVID and multidisciplinary expertise of those
supporting and caring for those affected as well as specific clinical,
medical, public health, behavioral health, human services, employment,
data science, and research expertise. The membership of the Committee
will reflect diverse individuals or organizations including underserved
populations, with a focus on health equity.
The following areas of expertise will be considered in selecting
the voting members with the goal of achieving a balanced membership in
terms of points of view, expertise, and groups represented and
functions to be performed by the Committee.
Long COVID and related groups: Representation from individuals
living with Long COVID and organizations directly engaged in supporting
people living with Long COVID.
Professional Associations: Representation from medical
professional, behavioral health and human services associations
representing practitioners caring for people with Long COVID, including
those representing the primary healthcare system.
Disability and Chronic Illness Groups: Representation from
associations, researchers, or organizations focused on disability and
chronic illness, and their possible interplay with Long COVID.
Public Health and related groups: Representation from public health
groups supporting communities in addressing the impacts of Long COVID.
Healthcare and Social Care Providers: Clinical care settings and
health systems involved in providing care for patients with Long COVID,
including in underserved areas, such as rural communities and
communities disproportionately impacted by Long COVID.
Employee and Employer Related Groups: Representation from employee
and employer experts, attorneys, or organizations involved in
addressing the impacts of Long COVID in the workplace, including
discrimination.
Research: Researchers and research institutions involved in Long
COVID and associated conditions research.
Non-voting Industry Representatives: Those involved in, or
representing those involved in, Long COVID research and development,
including prevention, diagnostics, and treatment will be designated to
represent the interests of this sector.
[[Page 80320]]
Non-voting Federal Liaisons, without limit, may be solicited, as
needed, as ex officio members.
Equal opportunity practices regarding membership appointments to
the Committee will be aligned with HHS policies. To the extent
possible, HHS will ensure the Committee membership is balanced in
expertise, experience, education, and institutional affiliation.
Members of the Committee will be classified as Special Government
Employees (SGE) during their term of appointment and, as such, are
subject to the ethical standards of conduct for federal employees. Upon
entering the position and annually throughout the term of appointment,
members of the Committee will be required to complete and submit a
report of their financial holdings.
Nominations and Appointments for Memberships: Nominees, including
self-nominees, will be considered for appointment as members of the
Committee. Only complete nomination packages submitted on time will be
considered. To be considered for an appointment, submission of the
following information for each nominee is required: (1) a cover letter
that clearly states the name and place of work of the nominee, the
rationale for the nomination, and a statement that the nominee would be
willing to serve as a member of the Committee, if selected; (2) the
name, address, telephone number, and email address for the individual
being nominated and the nominator, if applicable; and (3) a copy of the
nominee's resume or curriculum vitae. Nominees with no professional
affiliation may submit an optional letter of recommendation.
The curriculum vitae should include the following information: (a)
education; (b) experience (current and former); (c) affiliations; (d)
current memberships (expert panels, committees, or other relevant
groups, including positions held); (e) any peer-reviewed publications
(for past 5 years); (f) any oral presentations (for past 5 years); (g)
editorials, opinion pieces, and blogs (for past 5 years); (h) grants,
contracts, or research funding (for past 15 years); (i) name of any
corporation, professional society, association, panel, company, firm,
government agency (Federal, State, and local), research organization,
educational institution, committee, or other organization or
institution (government, private, and not-for-profit; domestic and
foreign) in which the nominee's services have been, will be, or are
expected to be provided, with or without compensation, including on a
part-time or seasonal basis as an officer, medical staff, board member,
owner, trustee, director, expert advisor, consultant (paid or unpaid),
official spokesperson, member of speakers bureau, or expert witness
(for past 5 years and upcoming); (j) other paid travel or honoraria
received, not included above (for past 5 years). If the nominee does
not have anything to report for the sections, indicate ``none.'' Web
links to publications, presentations, and other materials available
online are requested, when available.
Where prohibited by Federal law or regulations, nominations will
not be accepted directly from HHS research and promotion boards. Self-
nominations and nominations by members of research and promotion boards
in their individual capacity will be considered. Federal employees
should not be nominated for consideration for appointment to this
Committee.
Dated: November 2, 2023.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2023-24586 Filed 11-16-23; 8:45 am]
BILLING CODE 4150-03-P
